RGMa inhibition with human monoclonal antibodies promotes regeneration, plasticity and repair, and attenuates neuropathic pain after spinal cord injury. (Q41620170)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | RGMa inhibition with human monoclonal antibodies promotes regeneration, plasticity and repair, and attenuates neuropathic pain after spinal cord injury. |
scientific article |
Statements
RGMa inhibition with human monoclonal antibodies promotes regeneration, plasticity and repair, and attenuates neuropathic pain after spinal cord injury (English)
Andrea J Mothe
Nardos G Tassew
Alirezha P Shabanzadeh
Romeo Penheiro
Lili Huang
Christine Grinnell
Yi-Fang Cui
Emma Fung
Bernhard K Mueller
Charles H Tator
5 September 2017
5 September 2017
1 reference